好娃娃品牌怎么样 申请店铺

赛诺菲集团是一家全球领先的多元化医药健康企业，专注于患者需求，传播健康。

赛诺菲的业务覆盖疫苗、处方药、健康药业产品和动物保健产品，拥有10万余名员工、遍及100多个国家。

赛诺菲是首批在中国开设办事处的跨国制药集团，也是国内增长最快的医药健康企业之一。目前，赛诺菲在中国200多个城市拥有6500余名员工。

赛诺菲一直以来秉承对中国的承诺。1982年，赛诺菲跻身首批在中国开设办事处的跨国制药企业。今天，赛诺菲已成为中国医药健康市场的领军企业。赛诺菲的中国总部位于上海，并在北京、天津、沈阳、济南、上海、杭州、南京、武汉、成都、广州和乌鲁木齐共设11家区域办公室。

好娃娃®品牌，创立于2000年，10年以来，一直专注于儿童健康领域，就像妈妈对待孩子一样，用心发现孩子最常见的健康问题，用心照顾孩子健康的每一方面，研制出了10余款儿童健康产品，涵盖了感冒、咳嗽、食欲不振、消化不良、腹泻、成长发育这六大儿童主要的健康需求。

2011年，赛诺菲完成了对BMP太阳石的收购，籍此拥有属于太阳石(唐山)药业有限公司的国内领先儿童药品品牌-好娃娃®因为持之以恒的用心，拥有好娃娃®品牌的太阳石(唐山)药业有限公司于2010年荣获了世界卫生组织儿童合作中心和中华预防医学会儿童保健分会联合颁发的“量身定制儿童药物特别贡献企业”奖。

好娃娃®致力于帮助每一位妈妈更懂孩子，所以一直致力于向妈妈们传递专业的健康信息，帮助妈妈们更自信、更准确、更好地照顾孩子的健康。

从预防到治疗，赛诺菲全方位满足中国的公共健康需求。集团的疫苗事业部赛诺菲巴斯德是中国领先的疫苗企业。赛诺菲在心血管/血栓、糖尿病、肿瘤、罕见病、内科和中枢神经系统等关键的治疗领域拥有领先产品。2010年，杭州赛诺菲民生健康药业有限公司的成立标志着赛诺菲进入中国的非处方药市场。

赛诺菲目前在中国拥有六家生产基地，包括北京制药工厂、杭州制药工厂、杭州赛诺菲民生健康药业工厂、南昌梅里亚动物保健工厂、深圳赛诺菲巴斯德疫苗工厂以及唐山健康药业工厂。

在中国，赛诺菲具有从药物靶点发现到后期临床研究的整体研发实力。集团在上海设有中国研发中心和亚太研发中心，并在北京和成都分别设有研发机构。自2008年以来，赛诺菲与中国权威科研机构开展了30多项战略合作，在癌症、干细胞、糖尿病和老年疾病等前沿研究领域探索创新药物。

Sanofi group is a leading diversified pharmaceutical and health enterprise in the world, focusing on the needs of patients and spreading health. Sanofi's business covers vaccines, prescription drugs, health pharmaceutical products and animal health products, with more than 100000 employees in more than 100 countries. Sanofi is one of the first multinational pharmaceutical groups to set up offices in China and one of the fastest growing pharmaceutical and health enterprises in China. At present, Sanofi has more than 6500 employees in more than 200 cities in China. Sanofi has always been committed to China. In 1982, Sanofi was among the first multinational pharmaceutical companies to open offices in China. Today, Sanofi has become a leading enterprise in China's pharmaceutical and health market. Sanofi is headquartered in Shanghai and has 11 regional offices in Beijing, Tianjin, Shenyang, Jinan, Shanghai, Hangzhou, Nanjing, Wuhan, Chengdu, Guangzhou and Urumqi. Haowa brand, founded in 2000, has been focusing on the field of children's health for 10 years. Just like a mother treating her children, she has carefully found the most common health problems of her children, taken care of every aspect of their health, and developed more than 10 children's health products, covering six major children: cold, cough, anorexia, dyspepsia, diarrhea, and growth and development Health needs. In 2011, Sanofi completed the acquisition of BMP Sunstone, which is the leading domestic children's drug brand of Sunstone (Tangshan) Pharmaceutical Co., Ltd. - haowa (Tangshan) Pharmaceutical Co., Ltd. because of its persistent efforts, the company won the World Health Organization children's cooperation center and the children's health branch of China Preventive Medicine Association in 2010 "Customized children's drug special contribution enterprise" award. Good baby is committed to helping every mother understand children better, so it has always been committed to delivering professional health information to mothers, helping mothers to be more confident, more accurate and better care for their children's health. From prevention to treatment, Sanofi meets China's public health needs in all aspects. Sanofi Pasteur, the group's vaccine division, is a leading vaccine company in China. Sanofi has leading products in key treatment fields such as cardiovascular / thrombosis, diabetes, tumor, rare disease, internal medicine and central nervous system. In 2010, the establishment of Hangzhou Sanofi Minsheng Health Pharmaceutical Co., Ltd. marked Sanofi's entry into the over-the-counter drug market in China. Sanofi currently has six production bases in China, including Beijing pharmaceutical factory, Hangzhou pharmaceutical factory, Hangzhou Sanofi Minsheng health pharmaceutical factory, Nanchang Meiya animal health factory, Shenzhen Sanofi Pasteur vaccine factory and Tangshan health pharmaceutical factory. In China, Sanofi has the overall R & D strength from drug target discovery to later clinical research. The group has China R & D center and Asia Pacific R & D center in Shanghai, and R & D institutions in Beijing and Chengdu respectively. Since 2008, Sanofi has carried out more than 30 strategic cooperation with authoritative scientific research institutions in China to explore innovative drugs in the frontier research fields of cancer, stem cells, diabetes and elderly diseases.

本文链接： https://brand.waitui.com/6746b7a50.html 联系电话：021-22266666,400-8208884